Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:00 PM UTC
| NCT Number | NCT06556563 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | PHASE3 |
| Target Enrollment | 741 participants |
| Active Locations | 36 sites in the US |
| Sponsor | NovoCure GmbH |
| Last Updated on CT.gov | August 19, 2026 (Aug 19, 2026) |
As of October 15, 2026: Clinical trial NCT06556563 is currently recruiting participants. This phase3 study for glioblastoma is actively seeking new participants at 36 locations across the United States. The study is sponsored by NovoCure GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06556563 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06556563 was last updated Aug 19, 2026 (August 19, 2026). HelloStudys verifies this status automatically.